Cargando…
Serum N-glycome alterations in colorectal cancer associate with survival
Proteins are routinely measured in clinical laboratories for diagnosis, prognosis and therapy monitoring. Nevertheless, both test improvements (performance) and innovations (biomarkers) are needed, and protein N-glycosylation offers a rich source of potential markers. Here, we have analyzed the tota...
Autores principales: | de Vroome, Stefan W., Holst, Stephanie, Girondo, Mar Rodriguez, van der Burgt, Yuri E.M., Mesker, Wilma E., Tollenaar, Rob A.E.M., Wuhrer, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078140/ https://www.ncbi.nlm.nih.gov/pubmed/30093973 http://dx.doi.org/10.18632/oncotarget.25753 |
Ejemplares similares
-
Serum N‐Glycome analysis reveals pancreatic cancer disease signatures
por: Vreeker, Gerda C. M., et al.
Publicado: (2020) -
N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
por: Boyaval, Fanny, et al.
Publicado: (2021) -
Automated Plasma
Glycomics with Linkage-Specific Sialic
Acid Esterification and Ultrahigh Resolution MS
por: Vreeker, Gerda C. M., et al.
Publicado: (2018) -
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
por: Hanna-Sawires, Randa G., et al.
Publicado: (2021) -
Serum N-Glycosylation RPLC-FD-MS Assay to Assess Colorectal Cancer Surgical Interventions
por: Moran, Alan B., et al.
Publicado: (2023)